← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Opticyte, Inc.
Seattle, WA
$4,030,862
Total funding
2
Grants
Funding over time
peak $998.6K · FY2015–22$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,030,862 · 2
By mechanism
R44$3,880,862 · 1
R41$150,000 · 1
Investigators at Opticyte, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$998,586
R44 · FY2020 · HL
Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$971,485
R44 · FY2021 · HL
Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$910,791
R44 · FY2022 · HL
Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$500,000
R44 · FY2017 · HL
Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$500,000
R44 · FY2016 · HL
Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$150,000
R41 · FY2015 · HL